Are surrogate markers adequate to assess cardiovas... [JAMA. 1999]

Cited by 11 PubMed Central articles

The role of surrogate endpoints in the evaluation of efficacy and safety of therapeutic interventions in diabetes mellitus.
Wieczorek A, Rys P, Skrzekowska-Baran I, Malecki M. Rev Diabet Stud. 2008 Fall; 5(3):128-35. Epub 2008 Nov 10.

[Rev Diabet Stud. 2008]
Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.
Bouxsein ML, Delmas PD. J Bone Miner Res. 2008 Aug; 23(8):1155-67.

[J Bone Miner Res. 2008]
ReviewAdvancing outcome measures for the new era of drug development in cystic fibrosis.
Mayer-Hamblett N, Ramsey BW, Kronmal RA. Proc Am Thorac Soc. 2007 Aug 1; 4(4):370-7.

[Proc Am Thorac Soc. 2007]
» See all...

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.